139 related articles for article (PubMed ID: 1283895)
1. Prostate-specific antigen and diagnosing early malignancies of the prostate.
Oesterling JE
J Cell Biochem Suppl; 1992; 16H():31-43. PubMed ID: 1283895
[TBL] [Abstract][Full Text] [Related]
2. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.
Oesterling JE
J Urol; 1991 May; 145(5):907-23. PubMed ID: 1707989
[TBL] [Abstract][Full Text] [Related]
3. Prostatic specific antigen.
el-Shirbiny AM
Adv Clin Chem; 1994; 31():99-133. PubMed ID: 7533474
[TBL] [Abstract][Full Text] [Related]
4. Role of prostate-specific antigen and digital rectal examination in the detection of prostate cancer.
Yamamoto M; Hibi H; Miyake K
Int J Urol; 1994 Mar; 1(1):74-7. PubMed ID: 7543009
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen. Current role in diagnostic pathology of prostate cancer.
Bostwick DG
Am J Clin Pathol; 1994 Oct; 102(4 Suppl 1):S31-7. PubMed ID: 7524305
[TBL] [Abstract][Full Text] [Related]
6. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.
Oesterling JE; Jacobsen SJ; Chute CG; Guess HA; Girman CJ; Panser LA; Lieber MM
JAMA; 1993 Aug; 270(7):860-4. PubMed ID: 7688054
[TBL] [Abstract][Full Text] [Related]
7. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations.
Gohji K; Nomi M; Egawa S; Morisue K; Takenaka A; Okamoto M; Ohori M; Fujii A
Cancer; 1997 May; 79(10):1969-76. PubMed ID: 9149025
[TBL] [Abstract][Full Text] [Related]
8. Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia.
Partin AW; Carter HB; Chan DW; Epstein JI; Oesterling JE; Rock RC; Weber JP; Walsh PC
J Urol; 1990 Apr; 143(4):747-52. PubMed ID: 1690309
[TBL] [Abstract][Full Text] [Related]
9. Biology of prostate-specific antigen.
Balk SP; Ko YJ; Bubley GJ
J Clin Oncol; 2003 Jan; 21(2):383-91. PubMed ID: 12525533
[TBL] [Abstract][Full Text] [Related]
10. Hepsin immunohistochemical expression in prostate cancer in relation to Gleason's grade and serum prostate specific antigen.
Goel MM; Agrawal D; Natu SM; Goel A
Indian J Pathol Microbiol; 2011; 54(3):476-81. PubMed ID: 21934206
[TBL] [Abstract][Full Text] [Related]
11. Use of Digital Rectal Examination as an Adjunct to Prostate Specific Antigen in the Detection of Clinically Significant Prostate Cancer.
Halpern JA; Oromendia C; Shoag JE; Mittal S; Cosiano MF; Ballman KV; Vickers AJ; Hu JC
J Urol; 2018 Apr; 199(4):947-953. PubMed ID: 29061540
[TBL] [Abstract][Full Text] [Related]
12. [Prostate-specific antigen. The role in the prostate cancer diagnosis].
Sánchez-Martínez LC; Paredes-Solís CA; Hernández-Ordóñez OF; Sánchez-Ruvalcaba IR
Rev Med Inst Mex Seguro Soc; 2013; 51(2):124-6. PubMed ID: 23693096
[TBL] [Abstract][Full Text] [Related]
13. Detection of prostate cancer and changes in prostate-specific antigen (PSA) six months after surgery for benign prostatic hyperplasia in patients with elevated PSA.
Ozden C; Inal G; Adsan O; Yazici S; Ozturk B; Cetinkaya M
Urol Int; 2003; 71(2):150-3. PubMed ID: 12890951
[TBL] [Abstract][Full Text] [Related]
14. Correlation of prostate-specific antigen and prostate-specific antigen density with outcome of prostate biopsy.
Bare R; Hart L; McCullough DL
Urology; 1994 Feb; 43(2):191-6. PubMed ID: 7509526
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen density: correlation with histological diagnosis of prostate cancer, benign prostatic hyperplasia and prostatitis.
van Iersel MP; Witjes WP; de la Rosette JJ; Oosterhof GO
Br J Urol; 1995 Jul; 76(1):47-53. PubMed ID: 7544204
[TBL] [Abstract][Full Text] [Related]
16. Serum-to-urinary prostate-specific antigen ratio: a potential means of distinguishing benign prostatic hyperplasia from prostate cancer.
Irani J; Millet C; Levillain P; Doré B; Begon F; Aubert J
Eur Urol; 1996; 29(4):407-12. PubMed ID: 8791046
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific antigen: critical issues for the practicing physician.
Ruckle HC; Klee GG; Oesterling JE
Mayo Clin Proc; 1994 Jan; 69(1):59-68. PubMed ID: 7505869
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen (PSA) as a possible biomarker in non-prostatic cancer: A review.
Pérez-Ibave DC; Burciaga-Flores CH; Elizondo-Riojas MÁ
Cancer Epidemiol; 2018 Jun; 54():48-55. PubMed ID: 29579692
[TBL] [Abstract][Full Text] [Related]
19. Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios.
Oesterling JE; Jacobsen SJ; Klee GG; Pettersson K; Piironen T; Abrahamsson PA; Stenman UH; Dowell B; Lövgren T; Lilja H
J Urol; 1995 Sep; 154(3):1090-5. PubMed ID: 7543605
[TBL] [Abstract][Full Text] [Related]
20. Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng./ml.
Morote J; Raventós CX; Lorente JA; Lopez-Pacios MA; Encabo G; de Torres I; Andreu J
J Urol; 1997 Aug; 158(2):502-4. PubMed ID: 9224333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
